Sanfilippo syndrome gene therapy could be filed in US next year, Abeona
Abeona Therapeutics says it plans to file its single injection adeno-associated virus (AAV) gene therapy for Sanfilippo syndrome in the US in late 2018.
Archives for April 10, 2017
GE Healthcare teams with CBMG to develop CAR-T and stem cell production tech
GE Healthcare has agreed to help Cellular Biomedicine Group (CBMG) develop CAR-T and stem cell production technologies to support its aim of making 10,000 cancer cell therapies a year.
US biosimilars: Quality trumps manufacturing location, say physicians
American-made biosimilars hold no advantage in the US market according to patient and physician groups which place emphasis on trusted and reputable manufacturers instead.